東北大学病院 腎臓・高血圧内科





  1. Saito A, Sugawara A, Uruno A, Kudo M, Kagechika H, Sato Y, Owada Y, Kondo H, Sato M, Kurabayashi M, Imaizumi M, Tsuchiya S, Ito S: All-trans retinoic in Vitro angiogenesis via retinoic acid receptor: Possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling; Endocrinology 148(3); 1412-1423, 2007
  2. Nakagawa Y, Mori K, Hoshikawa S, Ozaki H, Ito S, Yoshida K: Development of Subclinical Hyperthyroidism due to Graves' Disease in a Hypothyroid Woman who had Undergone Hemithyroidectomy for Adenomatous Goiter and Radiotherapy for Nasopharyngeal Cancer: Endocrine Journal 54(1); 35-37, 2007
  3. Ogawa S, Takeuchi K, Mori T, Nako K, Ishizuka T, Ito S: Effect of increasing dose or combination of an initially recommended dose of angiotensin-converting enzyme inhibitors and angiotensin type-1 receptor blockers in suppression of diabetic nephropathy: a comparative study; Hypertension Res 30; 325-334, 2007
  4. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Estimation of glomerular filtration rate by the MDRD equation modified for Japanese patients with chronic kidney disease; Clin Exp Nephrol 11; 41-50, 2007
  5. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Prevalence of chronic kidney disease (CKD) in Japanese general population predicted by MDRD equation modified by a Japanese coefficient; Clin Exp Nephrol 11; 156-163, 2007
  6. Tanemoto M, Satoh F, Abe T, Ito S: To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not ?; J Hypertens 25(2); 480-481, 2007
  7. Tanemoto M, Abe M, Satoh F, Abe T, Satoh H, Ito S: Mesangial proliferative glomerulonephritis with aldosterone-producing adenoma; Clin Exp Nephrol 11; 164-167, 2007
  8. Mori K, Yoshida K, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Watanabe C: Methylmercury inhibition of type Ⅱ 5'-deiodinase activity resulting in a decrease in growth hormone production in GH3 cells; Toxicology 237; 203-209, 2007
  9. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S, INNOVATION Study Group: Prevention of transition from incipient to overt nephrology with telmisartan in patients with type 2 diabetes; Diabetes Care 30(6); 1577-1578, 2007
  10. Tanemoto M, Satoh F, Abe T, Ito S: To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not?-round 2; J Hypertens 25(7); 1517-1518, 2007
  11. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J, Totsune K, Hoshi H, Ito S, Imai Y: Kidney dysfunction as a risk factor for symptomatic stroke events in a general Japanese population- the Ohasama study; Nephrol Dial Transplant 22; 1910-1915, 2007
  12. Nakayama M, Saito K, Sato E, Nakayama K, Terawaki H, Ito S, Kohno M: Radical generation by the non-enzymatic reaction of methylglyoxal and hydrogen peroxide; Redox Report 12(3); 125-133, 2007
  13. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Yoshida K: Intrathyroidal persistence of human parvirus B19 DNA in a patients with Hashimoto's thyroiditis; J Infect 55; e29-e31, 2007
  14. Vanbelleghem H, Vanholder R, Levin NW, Becker G, Craig JC, Ito S, Lau J, Locatelli F, Zoccali C, Solez K, Hales M, Lameire N, Eknoyan G; The Kidney Disease: Improving Global Outcomes website: Comparison of guidelines as a tool for harmonization; Kidney Int 71; 1054-1061, 2007
  15. Tanemoto M, Takase K, Yamada T, Satoh A, Abe T, Ito S: Dilation of Renal Artery Stenosis after Administration of Losartan; Hypertens Res 30; 999-1002, 2007
  16. Naritomi H, Fujita T, Ito S, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Design and Baseline Characteristics of and Observational Study in Japanese Patients with Hypertension: Japan Hypertension Evaluation with Angiotensin Ⅱ Antagonist Losartan Therapy (J-HEALTH); Hypertens Res 30; 807-814, 2007
  17. Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S: Localization of Aldosterone-Producing Adrenocortical Adenomas: Significance of Adrenal Venous Sampling; Hypertens Res 30(11); 1083-1095, 2007
  18. Nakayama M, Kabayama S, Terawaki H, Nakayama K, Kato K, Sato T, Ito S: Less oxidative hemodialysis sodium rendered by cathode-side application of electrolyzed water; Hemodialysis Int 11; 322-327, 2007
  19. Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T, Ito S: Reduction of serum antioxidative capacity during hemodialysis; Clin Exp Nephrol 11; 218-224, 2007
  20. Morimoto R, Satoh F, Murakami O, Totsune K, Suzuki T, Sasano H, Ito S, Takahashi K: Expression of adrenomedullin2/intermedin in human brain, heart, and kidney; Peptide 28; 1095-1103, 2007
  21. Morimoto R, Satoh F, Murakami O, Totsune K, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K: Immunolocalization of urotensin Ⅱ and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues; Peptide 29; 873-880, 2007
  22. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan; Am J Kidney Dis 50; 927-937, 2007


  1. 菅原明、伊藤貞嘉:ストレスとしてのホルモン疾患と心疾患;CARDIAC PRACTICE18(1);37-39,2007
  2. 伊藤貞嘉:CKDと心血管事故;治療学41(2);165-168,2007
  3. 伊藤貞嘉:特集 心腎疾患の病態と対策 心血管疾患と腎疾患の連関;血圧14(3);260-265,2007
  4. 伊藤貞嘉:特集 ベッドサイド必携二次性高血圧 治す 9-a 二次性高血圧の治療オプション 腎血管性高血圧;Heart View 11(4);414-418,2007
  5. 伊藤貞嘉:腎と高血圧 最近の話題;Modern Physician 27(3);365-369, 2007
  6. 竹内和久、伊藤貞嘉:特集 高血圧と腎障害-Up to Date 虚血性腎症;Nephrology Frontier 6(1); 37-42, 2007
  7. 伊藤貞嘉:利尿薬;治療薬UP-TO-DATE2007;205-207;メディカルレビュー社,2007
  8. 伊藤貞嘉:C.糖尿病の治療 23糖尿病患者の血圧管理;診断と治療95Suppl.;253-261,2007
  9. 伊藤貞嘉:CKDとCVD-心腎連関-;日医雑誌136(3);JH9-JH12,2007
  10. 伊藤貞嘉:特集 CKD(慢性腎臓病) 慢性腎臓病対策と治療-血圧管理の面から-;Mebio24(7);107-115, 2007
  11. 小川晋、伊藤貞嘉:アンジオテンシンⅡと腎臓-特に糖尿病性腎症の治療におけるACE阻害薬、ARBの意義-:BIO Clinica 22(1);43-48,2007
  12. 伊藤貞嘉:微量アルブミン尿と血管内皮障害-心腎相関-;内分泌・糖尿病科24(4);369-374,2007
  13. 伊藤貞嘉:質疑応答Q&A 二次性高血圧の診断と治療;日本医事新報4339;86-87,2007
  14. 伊藤貞嘉:心・腎連関;綜合臨牀56(6);2028-2034,2007
  15. 佐藤文俊、伊藤貞嘉:副腎静脈サンプリング;医学のあゆみ221(9);777-779,2007
  16. 伊藤貞嘉:知っておきたい血管医学用語15 CKD;Vascular Medicine 3(3);268-271,2007
  17. 伊藤貞嘉:心腎連関;呼吸と循環55(8);891-897,2007
  18. 伊藤貞嘉:CASE‐J -腎臓-;Angiotensin Research 4(3);149-151,2007
  19. 伊藤貞嘉:心臓財団虚血性心疾患セミナー 腎血管性高血圧を見逃さないために;心臓39(7);695-696, 2007
  20. 伊藤貞嘉:糖尿病性腎症治療におけるRAS阻害薬の新展開;日腎会誌49(5);485-490, 2007
  21. 伊藤貞嘉:日本人の貢献 レニン・アンジオテンシン系;日本腎臓学会創立50周年記念誌;103-106, 2007
  22. 伊藤貞嘉:Ⅰ.診断と病態 4.二次性高血圧の診断;日本内科学会雑誌96(1);23-28,2007
  23. 伊藤貞嘉:Symposium 第3回TOPフォーラム 第2部 心疾患における腎機能調節の異常とその機序;Therapeutic Research 28(8);1606-1612,2007
  24. 中山昌明、中山恵輔、寺脇博之、伊藤貞嘉:慢性腎臓病における心血管系疾患の疫学と病態;CURRENT THERAPY 25(9);729-733,2007
  25. 山岸俊夫、伊藤貞嘉:合併症を伴う高血圧治療の実際 腎臓病;綜合臨牀56(9);2724-2728,2007
  26. 伊藤貞嘉:CKDと心血管イベントの関係 CKDがひきおこす心血管イベント;実験治療687;110-115,2007
  27. 伊藤貞嘉:CKD(慢性腎臓病)-日本人の新しいGFR推算式への期待 CKDはCVDのリスクファクター-心腎相関;医学のあゆみ222(10);789-793,2007
  28. 伊藤貞嘉:Information Up-to-Date ACE阻害薬、ARBによる糖尿病性腎症の治療;血圧14(10);946-947,2007
  29. 伊藤貞嘉:Ⅱ-16. 腎と関係の深い高血圧 腎血管性高血圧[成人];日本医師会雑誌136特別号(2)腎・泌尿器疾患診療マニュアル-小児から成人まで;S312-S313, 2007
  30. 佐藤博、伊藤貞嘉、斎藤喬雄、相馬淳、黒澤孝成、京極芳夫:特集 遺伝性腎疾患の診断・治療 Collagenofibrotic glomerulonephropathy;医学と薬学58(3);405-408,2007
  31. 中道崇、伊藤貞嘉:慢性腎疾患;Medicina44(1);136-138,2007
  32. 中道崇、森建文、佐藤寿伸、米城淑美、遠藤聡、Matlubur Rahman、朱万君、胡春艶、細谷拓真、杉浦章、佐藤博、伊藤貞嘉:Thy-1腎炎の慢性化と酸化ストレスの関与 Therapeutic Research 28(10): 1929-30,2007